These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8871454)

  • 1. Impaired glucose tolerance and unidentified diabetes.
    Heine RJ; Mooy JM
    Postgrad Med J; 1996 Feb; 72(844):67-71. PubMed ID: 8871454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-prandial hyperglycemia and microvascular complications.
    Dhanwal D; Tandon N
    J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study.
    Bonora E; Kiechl S; Oberhollenzer F; Egger G; Bonadonna RC; Muggeo M; Willeit J
    Diabetologia; 2000 Feb; 43(2):156-64. PubMed ID: 10753036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
    Igarashi Y; Kawamori R
    Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes mellitus and epidemiology: apropos of the meeting on the epidemiology of diabetes mellitus].
    Simon D
    Pathol Biol (Paris); 1994 Feb; 42(2):129-32. PubMed ID: 8090556
    [No Abstract]   [Full Text] [Related]  

  • 13. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 16. Postprandial hyperglycemia as an etiological factor in vascular failure.
    Node K; Inoue T
    Cardiovasc Diabetol; 2009 Apr; 8():23. PubMed ID: 19402896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study of brain macrovascular reactivity in impaired glucose tolerance and type-2 diabetes: Quantitative internal carotid artery blood flow using magnetic resonance phase contrast angiography.
    Selvarajah D; Hughes T; Reeves J; Boland E; Marques J; Gandhi R; Griffiths PD; Tesfaye S; Wilkinson ID
    Diab Vasc Dis Res; 2016 Sep; 13(5):367-72. PubMed ID: 27190084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study.
    White B; Chamberlain N
    N Z Med J; 2009 May; 122(1295):28-37. PubMed ID: 19648984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.